NCT07476807Enrolling By Invitation不适用
TREATS: Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study
干预措施
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- time to clinical resolution
研究概览
简要总结
This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants must meet all of the following criteria:
- •Adult oncology or haematology patients currently receiving systemic anti-cancer therapy (SACT).
- •New-onset dermatologic toxicity consistent with a recognised adverse effect of the administered SACT.
- •Skin toxicity severity graded ≤ Grade 2 in accordance with UKONS assessment criteria.
- •Clinically stable condition not requiring urgent in-person evaluation.
- •Access to, and ability to use, a smartphone or computer with adequate internet connectivity to participate in telemedicine consultations.
排除标准
- •Participants will be excluded if any of the following criteria apply:
- •Skin toxicity graded ≥ Grade 3 according to UKONS assessment criteria.
- •Clinical status requiring urgent or immediate face-to-face medical assessment.
- •Dermatologic toxicity that is atypical, unexpected, or not consistent with known SACT-related adverse effects.
- •Inability to access or effectively use the required telemedicine technology.
研究组 & 干预措施
Remote tele medicine assessment
Other
use of telemedicine
干预措施: telem healthassessment (Other)
结局指标
主要结局
time to clinical resolution
时间窗: 6 weeks
Number of days from first AHOS contact to documented resolution (Grade 0-1).
次要结局
- Escalation in person review(6 weeks)
- treatment modification reat(6 weeks)
- unscheduled acute contact(6 weeks)
- Patient-Reported Endpoints -Quality of Life (QoL) and patient satisfaction(6 weeks)
研究者
Margaret Burke
Research Nurse
Sligo General Hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
Phase 3 4
An interventional study in which participants affected with Karappan Eczema will be treated with Gowri chindamani chendooram Internal and Karappan thylam External for the treatment of Karappan EczemaCTRI/2025/02/080440National institute of siddha40
招募中
3 期
To study safety and efficacy of Methotrexate and Apremilast in the Management of Psoriasis.CTRI/2025/07/091790Government Institute of Medical Sciences (GIMS) Greater Noida124
招募中
3 期
Androgenic Alopecia TH07 Clinical TrialNCT07435012Triple Hair Inc420
尚未招募
不适用
Effect of Products on skin ageingCTRI/2024/08/073049Herbalife36
尚未招募
不适用
Allergy testing in lips and eyelid allergyCTRI/2024/09/073308Dr Aravind Suprakasan20